ASD Healthcare

World Courier

American Health Packaging

ICS - AmerisourceBergen

IntrinsiQ Specialty Solutions

Triose, Inc.

Besse Medical

AmerisourceBergen

Innomar Strategies

MWI Animal Health

ION Oncology Practice Network

US Bioservices

Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We connect manufacturers, providers, and patients to ensure that anyone can get the therapies they need, where and when they need them. We also help our partners bring their innovations to patients more efficiently to accelerate positive outcomes.
 
Becoming Cencora has allowed us to combine all the companies and services of AmerisourceBergen. Now, as a unified and internationally inclusive brand, we’re continuing to invest in and focus on our core pharmaceutical distribution business, while also growing our platform of pharma and biopharma services to support pharmaceutical innovation and access. Our 46,000+ worldwide team members are shaping the future of healthcare through the power of our purpose: We are united in our responsibility to create healthier futures.
 
AmerisourceBergen, now Cencora, is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $230 billion in annual revenue.

OneOncology

Profarma

Cencora

Home infusions have been prominent since the 1970s, but now is a critical time for health systems to have a comprehensive infusion strategy. 

Our Toni Giglio spoke with Dan Teich, vice president of Performance Based Contracting and Justin Whitsett, senior director, Infusion Portfolio Solution about why an infusion strategy can retain revenue and improve patient outcomes. Read the article: https://ow.ly/VzLC50QtHyT

Patients with life-threatening conditions need access to investigational medicines outside of clinical trials. Expanding Early Access Programs can help. 
 
Patrick Larcier, PharmD, MBA, Senior Director of Strategic Product Development Solutions at PharmaLex discusses the value of these programs in a guest piece for pharmaphorum. Learn about the impacts of the real-word data they give us here: https://ow.ly/si4550QtHre 

In the face of pharmacist burnout and labor shortages, partnerships with distributors are fundamental to pharmacies. Our experts guide pharmacies facing new challenges amid the shifting healthcare landscape and help them create a more significant impact in the communities they serve.

Claire Biermaas, President of Corporate Partnerships, shares how we serve as allies to pharmacies in a recent Pharmacy Times interview. https://ow.ly/XBEM50QtHoE

The cell and gene therapy (CGT) sector is entering a new era.  
 
The path to commercialization of CGT products is complex and lined with challenges that can delay market entry and impact product success. Read our experts’ step-by-step guide to CGT commercialization: https://ow.ly/4lGR50QsKcF

Cencora, formerly AmerisourceBergen, is making a positive impact in healthcare with our diverse global network of 46,000+ team members. We earned a top score of 100 on the Human Rights Campaign Foundation’s 2023-2024 Corporate Equality Index, as well as a top score of 100 on the Disability Equality Index. 

We all feel a true sense of belonging and connection to our purpose, and we’re encouraged to be our authentic selves at work. Having diverse perspectives, backgrounds, and experiences at every level of our company is what makes us stronger and more dynamic. It empowers our empathy and fuels our innovation. https://https://lnkd.in/g79XSJ7g

My GNP

ABC PassPort Nomad Returns and Claims

SmartSource

ABC PassPort Nomad - Receiving

MWI Mobile

OrderSpot

ABC PassPort Nomad - PI

AB Meeting

ABC PassPort Nomad Receiving

ABC PassPort Nomad Ordering

Domain Not Resolving

Apple Mobile Web Clips Icon

HSTS

DNSSEC

LetsEncrypt

Mobile Non Scaleable Content

nginx

reCAPTCHA

Cloudflare CDN

IPv6

SVP, Chief Information Security Officer

Alden Sutherland

VP, Associate General Counsel

Alicia Evans

Vice President - Knowledge Management & Associate General Counsel

Amy Coll

Assistant General Counsel

Andrew Schinzel

Service Owner - Director

Blesson Thonichalil

Bret Flaherty

President

Brian Ansay

V.P. Service Portfolio Owner, Corporate & Associate Services

Brian Mangiaracina

SVP, Community & Specialty Pharmacy and President, Good Neighbor Pharmacy

Brian Nightengale

President, American Health Packaging

Bruce Bennett

Henry W. McGee

Richard C. Gozon

Lon R. Greenberg

Ornella Barra

Michael Long

Steven H. Collis

Mark Durcan

Jane Henney

Sun Park

Executive Vice President and Group Chief Financial Officer

Mike Baca

Director, Digital Transformation & Mobility

Robert Mauch

EVP & Chief Operating Officer

Christine Lamm

Manager of Continuous Process Improvement

Chairman ,President & Chief Executive Officer

June Barry

Senior Vice President, Human Resources

Gina K. Clark

Executive Vice President and Chief Communications & Administration Officer

Lucien Napoleon Brunswig

Founder

OneOncology is a partnership of oncologists and industry leading experts driving the future of community-based cancer care in the US.

Profarma is a pharmaceutical wholesaler in Brazil.

Northeastern US Public Companies With More Than 500 Employees

Great Lakes Public Companies With More Than 500 Employees

Northeastern US Public Companies With More Than $100M in Revenue

Medical Public Companies With More Than $500 in Revenue

Cencora, a company building on the legacy of AmerisourceBergen, is a global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We connect our pharmaceutical partners, providers, and patients to ensure that anyone can get the therapies they need, where and when they need them. We also help our partners bring their innovations to patients more efficiently to accelerate positive outcomes.

Becoming Cencora has allowed us to combine all the companies and services of AmerisourceBergen. Now, as a unified and internationally inclusive brand, we’re continuing to invest in and focus on our core pharmaceutical distribution business, while also growing our platform of pharma and biopharma services to support pharmaceutical innovation and access. Our 46,000+ worldwide team members are shaping the future of healthcare through the power our purpose: We are united in our responsibility to create healthier futures.

AmerisourceBergen, now Cencora, is ranked #11 on the Fortune 500 and #24 on the Global Fortune 500 with more than $230 billion in annual revenue.

Headquartered in Valley Forge, Pennsylvania, AmerisourceBergen has locations around the world. It handles about 20% of all of the pharmaceuticals sold and distributed throughout the U.S.

They strive to take costs out of the healthcare system by using their scale and efficient operations to drive value for their customers. In addition to delivering pharmaceuticals on a just-in-time basis to tens of thousands of healthcare providers every day, they provide business support and consulting services to help their customers focus on their key strength—caring for patients.

AmerisourceBergen is committed to the safety and security of the nation’s pharmaceutical supply chain. They purchase all branded and generic pharmaceuticals only directly from the product’s manufacturer, except in the rare instance that they are required to do otherwise either by the manufacturer or a government agency.

Post-IPO Debt - Cencora

Post-IPO Secondary - Cencora

Corporate Venture Capital Fund

Advertising, Business and Retail Services

Conshohocken

Pennsylvania

United States

North America

CENCORA PRIVACY BREACH CLASS ACTION

Cencora Acquires Retina Care Practice Network For $4.6 Billion, Boosts Dividend On Better Than Expected Q4 Earnings

Sector Update: Health Care Stocks Mixed Late Afternoon

Cencora to buy Retina Consultants of America for $4.6B (NYSE:COR)

Cencora beats Q4 estimates (NYSE:COR)

Sector Update: Health Care

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America

India

Asia

United Kingdom

Europe

France

Sweden

Cencora owns PharMerica Corporation

Cencora owns Innomar Strategies

Cencora owns ASD Specialty Healthcare

Cencora owns AmerisourceBergen Specialty Group

Cencora owns AmerisourceBergen Drug Corporation

Cencora owns AmerisourceBergen Consulting Services

Cencora owns American Health Packaging

Cencora, Inc. sources and distributes pharmaceutical products. Its U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers. The company also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; and pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. The company's International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; and distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers and hospitals primarily in Europe. This segment also provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

news impact assignment basic	general
public peers	general
news daily refresh	general	Dec 21, 2024 6:00 PM	d5927e32
news processing daily refresh	general	Dec 20, 2024 5:27 PM	cd720d76
news impact assignment daily	general	Dec 20, 2024 6:54 AM	36d2a243
news processing basic	general
company summary	general	Dec 20, 2024 7:54 AM	43eaab12
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	0e37d650
crunchbase profile	general	Nov 25, 2024 11:37 AM	0789bf40
li profile	general	Feb 6, 2024 12:24 AM	36a31438
translate crunchbase fundingrounds	general	Nov 25, 2024 2:13 PM	732bdc45
peers	general	Feb 6, 2024 12:24 AM	4d8b9a7c
news basic	general	Nov 28, 2024 2:45 PM	2e197adb
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:CENCORA

Cencora, Inc.

Last Close

245.69

22/11 21:00

Market Cap

44.36B

Beta: -

Volume Today

948.95K

Avg: -